Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Cello Health Plc LSE:CLL London Ordinary Share GB00B0310763 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50p -0.39% 128.00p 127.00p 129.00p 128.50p 128.00p 128.50p 1,546 11:00:21
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 165.6 8.4 6.3 20.4 134.54

Cello Health Share Discussion Threads

Showing 751 to 774 of 1050 messages
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
DateSubjectAuthorDiscuss
02/4/2014
16:55
Thanks marky for the heads up! Great to see!
sagarn
02/4/2014
12:12
Cenkos upgrades Cello group Strong Delivery: Momentum in 2014 Cello Group has delivered a strong set of prelim results. This is reflected in terms of strong delivery across the whole group – with particularly strong growth in Cello Signal as it benefited from the improved economic outlook, a significant one-off rebranding project, and the full year contribution from Mash Healthcare. We upgrade our forecasts for FY2014 EPS by 2% to 7.4p, and publish new 2015E forecasts. BUY. Prelims vs. forecasts Revenues grew by 18.2% to £159.7m (2012: £135.1m) benefiting from good momentum in the global healthcare market and a strong return to growth for consumer - directly as a result of the stronger economic health of the UK economy. Gross profit of £74.7m (+14.8%, was well ahead of our forecasts of £69.7m). Headline PBT was £8.5m (+21.4%, beating our estimate of £8.4m. Headline EPS delivered was 7.25p (+13.8%) comfortably ahead of our forecasts of 6.84p. The final dividend for 2013 has been upgraded by 12.4%. The exit momentum exhibited by the group in Q4 2013 continues into '14. Cello Health 2013 was a strong year, benefiting from this increased activity positively impacting Cello Health's US business and is reflected in the numbers. The Cello Health re-branding exercise has been successfully implemented with new contract wins reflecting increased reach into the industry. The Mash acquisition has been particularly impressive driving sales growth and new business. Cello Signal (consumer) Cello Signal has had a highly successful year, enjoying a direct benefit from the growth in the UK economy. There has been an upswing in both the number and the quality of the contracts. Excluding a one off major branding contract, the underlying growth in revenues, gross profit and margins were at a double-digit level. The momentum and financial opportunity in Cello Signal is beginning to rival Cello Health and is now no longer dilutive to the group. Valuation We have used a comparable model to value both Cello Health and Cello Signal using closely related proxy companies. Combining both valuations on a blended PER delivers fair value for Cello Group share price of 143p (based on c.20x 2014E). Outlook & rating We upgrade our forecasts for 2014E: gross profit £76.6m vs. £72.4m [+6%], Adj. PBT £8.8m vs. £8.6m [+2%] and Adj. EPS 7.4p vs. 7.27p [+2%], and provide new 2015E forecasts for the first time. We reiterate our BUY rating.
markyjacob123
28/3/2014
09:58
Looking good, getting the recognition it deserves. First stop £1. Once it can crack that, £1.20 should be easily achieved.
sagarn
28/3/2014
09:16
New highs....good yield, debt nearly gone, rising profits....happy days hopefully and move towards the brokers £1.20+ targets,.... Were there any upgrades on latest rns?
qs99
27/3/2014
15:30
I do hope so!
qs99
27/3/2014
15:14
Looks to be breaking out here
tom111
27/3/2014
11:23
Pleased I stuck with it gla
tom111
27/3/2014
11:21
Indeed; strong L2 showing at the moment. Now its cleared 90p, next leg up imminent imo.
sagarn
27/3/2014
11:18
Moving up nicely now....
qs99
26/3/2014
21:35
I think when we least expect it will zoom up in one big leap say 10% or so. Certainly has all the hallmarks of wanting to catch up. Cracking results.
sagarn
26/3/2014
14:35
thank goodness! Great results and yet dips! frustrating, but IMO heading in the right direction as a business and market will catch up with that no doubt...
qs9
26/3/2014
13:53
Beginning to tick back up again...
sagarn
20/3/2014
19:54
Thanks dashton might get a bit of a rise tomorrow,Wall Street should help tonight as well
tom111
20/3/2014
17:12
Oh well, not a Tip Of The Week in Investors Chronicle, but still gets a reiterated Buy recommendation in an update today. For those with access: http://www.investorschronicle.co.uk/2014/03/20/shares/news-and-analysis/another-string-to-cello-s-bow-qyoNOiFVFCUa2sXyNHeqoM/article.html
dashton42
20/3/2014
10:27
I wonder if the results will be covered by Investors Chronicle; they do seem to be across the company quite well. In an ideal world, maybe they could make the "Tips of the Week", due out tonight.
dashton42
20/3/2014
08:37
Looks like some profit taking this morning, but reassuring they opened up on the morning so market liked the news initially. Should tick back up nicely.
sagarn
20/3/2014
07:43
only issue is current was helped by this one off branding contract - which drops off now. Its what put me off investing when I looked a few months back . Probably should have bought then but anyway lets see what the mkt says
felix99
20/3/2014
07:28
I agree - I haven't delved down into the figures (always a potentially dangerous omission), but at first glance, these results look stonkingly good! I really like the reduction in debt. Let's see if all of this was already factored into the share price or not.
dashton42
20/3/2014
07:27
agreed, well done them, with economic cycle in their favour at the mo as well, me thinks this really IMO should be over a quid...i'm a long-term holder....
qs9
20/3/2014
07:13
Wow! Seriously impressive results! Well done Cello! The outlook comments are especially bullish; only a few months into the year and their confident of the 2014 results: Current Trading and Outlook Cello begins 2014 with a good level of secured forward bookings and has also seen encouraging levels of new business wins so far this year. The strong balance sheet position of the Group means the Board is able to further invest in the growth strategy and continue to build the Cello brand in the global marketplace. This is an exciting time for the Group and the focus of the Board is set on driving profitable growth from the high level marketing advisory platform that has successfully been established. We have two well managed, well structured and highly competitive brands in Cello Health and Cello Signal. These are only now starting to show their true potential. At this early stage of the year, the Board is confident that expectations for 2014 will be met.
sagarn
20/3/2014
07:12
Ok those IMO are pretty great results and debt nearly gone....broker target price I believe was around £1.20 after trading update....wonder whether any upgrades will be forthcoming now after full year??
qs9
19/3/2014
09:49
QS99: Yes indeed tomorrow. Considering the recent update, can't imagine they will be anything but superb based on... RE-CLOSE TRADING UPDATE - YEAR ENDED 31 DECEMBER 2013 Strong performance, ahead of consensus market expectations Cello, the insight and strategic marketing group, today publishes the following trading update for the year ended 31 December 2013. Highlights - Strong trading for the year, revenues and headline profit before tax ahead of consensus market expectations - Cello Health delivers double digit revenue growth and maintains 20% operating margin - Cello Consumer delivers double digit revenue growth and restores double digit operating margin - Very strong cash conversion, reducing net debt to below expected levels - Growth investments in healthcare ventures prove successful in first year - Good new business pipeline in Q4 2013 underpins solid start to 2014 - Group rebranding initiatives proceeding to plan
sagarn
19/3/2014
09:35
Results tomorrow i believe...
qs99
06/3/2014
16:44
Results should be good,market thinks so as well by the look of it
tom111
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
Your Recent History
LSE
CLL
Cello Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190618 17:00:49